Tilak Pathology Private Limited
About Tilak Pathology Private Limited
Data last updated:
Tilak Pathology Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the dentalcare segment of the healthcare sector. It was incorporated on 23 December 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85110UP2002PTC027141.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Manglesh Kumar Srivastava and Savita Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Government Jubilee Inter College Road Bank Road, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.04 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹13.16 Lakh (net margin 47%) and EBITDA of ₹18.05 Lakh (EBITDA margin 64.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.
As per MCA filings, the company has satisfied charges of ₹2.4 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Tilak Pathology Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGovernment Jubilee Inter College Road Bank Road, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryHealthcare, Dentalcare, Nursing, Pathology
To see the full contact details of Tilak Pathology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tilak Pathology is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Tilak Pathology Private Limited, buy the company report.
Financials of Tilak Pathology Private Limited
FY 2025 filings availableTilak Pathology Private Limited reported revenue of ₹28.04 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 8% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 64.4% | ||||
| Net Profit Margin | 47% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tilak Pathology Private Limited, buy the company report.
Board of directors of Tilak Pathology Private Limited
Tilak Pathology has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manglesh Kumar Srivastava | Director | 23 Dec 2002 | 23 Years 10 Months | Current |
| Savita Srivastava | Director | 23 Dec 2002 | 23 Years 10 Months | Current |
Peer comparison
Tilak Pathology Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zotika India Pharmaceuticals Private Limited | ₹28.43 Lakh (FY 2025) | 53.0% | Bhopal, Madhya Pradesh, India | |||
| Flange Pharmaceuticals Private Limited | ₹28.4 Lakh (FY 2025) | -12.0% | Noida, Uttar Pradesh, India | |||
| Kailash Nursing Home and Maternity Centre Private Limited | ₹28.34 Lakh (FY 2024) | 2.0% | Muzaffarpur, Bihar, India | |||
| Nishit Clinical Laboratory Private Limited | ₹28.29 Lakh (FY 2024) | -8.0% | Delhi, India | |||
| Densoft Infotech Private Limited | ₹28.18 Lakh (FY 2025) | 32.0% | Mumbai, Maharashtra, India | |||
| Tilak Pathology Private Limitedthis company | ₹28.04 Lakh (FY 2025) | ₹13.16 Lakh | 47% | 8.0% | Gorakhpur, Uttar Pradesh, India | |
| Kesarwani Hospital and Research Institute Private Limited | ₹27.38 Lakh (FY 2024) | -5.0% | Uttar Pradesh, India | |||
| Mavodd Healthcare Private Limited | ₹27.06 Lakh (FY 2025) | 1514.0% | Maicha, Uttar Pradesh, India | |||
| Pratichi Multispeciality Hospital Private Limited | ₹26.94 Lakh (FY 2024) | 2.0% | Ahmedabad, Gujarat, India | |||
| Ratlam Diagnostic Private Limited | ₹26.93 Lakh (FY 2023) | 4071.0% | Ratlam, Madhya Pradesh, India | |||
| Rejuve India Meditour Private Limited | ₹26.92 Lakh (FY 2025) | 15.0% | New Delhi, Delhi, India |
To see the full peer comparison of Tilak Pathology Private Limited, buy the company report.
Shareholding
The shareholding of Tilak Pathology Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Tilak Pathology Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Feb 2005 | 90280792 | Union Bank of India | ₹2.4 Lakh | Satisfied |
To see the full charge records of Tilak Pathology Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Tilak Pathology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tilak Pathology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Tilak Pathology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Tilak Pathology Private Limited has 2 board changes on record since 2002: 2 appointments. The latest: Manglesh Kumar Srivastava was appointed as Director on 23 Dec 2002.
Frequently asked questions
Tilak Pathology is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in dentalcare, within the healthcare industry. It was incorporated on 23 December 2002 (24+ years old) and is registered under CIN U85110UP2002PTC027141.
Tilak Pathology has 2 current directors:
- Manglesh Kumar Srivastava - Director
- Savita Srivastava - Director
The latest financial statements of Tilak Pathology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Tilak Pathology is U85110UP2002PTC027141. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tilak Pathology was incorporated on 23 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Tilak Pathology by revenue are Zotika India Pharmaceuticals Private Limited, Flange Pharmaceuticals Private Limited, Kailash Nursing Home and Maternity Centre Private Limited, Nishit Clinical Laboratory Private Limited, Densoft Infotech Private Limited and 5 more, all in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Manglesh Kumar Srivastava was appointed as Director on 23 Dec 2002. Savita Srivastava was appointed as Director on 23 Dec 2002.
The registered office of Tilak Pathology is at Government Jubilee Inter College Road Bank Road, Gorakhpur, Uttar Pradesh, India – 273001.
Tilak Pathology operates in the healthcare industry, in the dentalcare segment.
Tilak Pathology has no open charges and satisfied charges of ₹2.4 Lakh as per latest MCA filings.
The compliance status of Tilak Pathology is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.